Saúde Pública/Medicina Humanitária
De acordo com estudo, vacinas contra SARS-CoV-2 são seguras e imunogênicas na maioria das pessoas com câncer.
15 Nov, 2021 | 13:56hComunicado de imprensa: SARS-CoV-2 vaccines are safe and immunogenic in most people with cancer, according to study – Harvard Medical School
Estudo original: Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – Journal of Clinical Oncology
Comentário do autor no Twitter (fio – clique para saber mais)
The CANVAX study is out in @JCO_ASCO! https://t.co/WKrU6dQIEB
Grateful to >1000 CANVAX participants, study leads ( @JustinGainor, @MGHPathology, @BalazsLab) and so many co-authors incl. @arthur_kim_ID, @KimberlyBlumen1, @joanhowMD, @dradityabardia
Much more to come!— Vivek Naranbhai, MD, PhD, DPhil (@vivek_naranbhai) November 10, 2021
#AHA21 – Estudo randomizado | Entre crianças e adolescentes submetidos a rastreamento ecocardiográfico e diagnosticados com doença cardíaca reumática latente, antibioticoprofilaxia secundária com penicilina G benzatina por 2 anos foi associada com redução da progressão ecocardiográfica (0,8 vs, 8,2% no grupo controle).
15 Nov, 2021 | 13:53hSecondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários:
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – American College of Cardiology
Comentários no Twitter
One of most important studies ever Rheumatic Heart Disease @NEJM https://t.co/U8FuNHLqCJ RCT evidence 2ry prophylaxis reduces progression latent RhD pic.twitter.com/UycTElr7QM
— Michael Marks (@dr_michaelmarks) November 13, 2021
Penicillin slowed the devastating impact of rheumatic heart disease among children in Uganda. Findings of a large-scale, randomized controlled trial were completed in Uganda. Group A strep underlies rheumatic heart disease. New England Journal of Medicine https://t.co/1PKFJ12FvC
— delthia ricks 🔬 (@DelthiaRicks) November 13, 2021
Mortalidade global, regional e nacional entre jovens de 10 a 24 anos, 1950–2019: uma análise sistemática do Global Burden of Disease Study 2019.
15 Nov, 2021 | 13:43hComentários: Nearly two-thirds of those who died young in 2019 were male, research finds – The Guardian
Comentários no Twitter (fio – clique para saber mais)
✨🆕✨#GBDStudy 2019 analysis published by @TheLancet examined the global, regional, and national #mortality among young people aged 10-24 between 1950-2019, finding that mortality increased in 2019 with age globally🌎, particularly in males
Read here ⤵https://t.co/6gprq6gM0Z
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) October 29, 2021
Estudo randomizado | BBV152 (vacina indiana COVAXIN) tem uma eficácia geral de 77,8% contra Covid-19 sintomática em adultos.
12 Nov, 2021 | 13:51hComentário convidado: Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 – The Lancet
Conteúdo relacionado: WHO issues emergency use approval for India’s Covaxin.
Comentário no Twitter
NEW—Interim data from a phase 3 trial of #BBV152, a COVID-19 vaccine developed in India, suggests it is safe and two doses offer 77.8% protection against symptomatic #COVID19. https://t.co/QWtz0AWd1X
— The Lancet (@TheLancet) November 11, 2021
Mortes de crianças e jovens na Inglaterra após infecção por SARS-CoV-2 durante o 1º ano da pandemia – “Ao todo, 99,995% das crianças e jovens com teste positivo para SARS-CoV-2 sobreviveram.”
12 Nov, 2021 | 13:48hConteúdo relacionado:
Study: Children and young people remain at low risk of COVID-19 mortality
Comentários no Twitter
Just published @NatureMedicine
An in-depth analysis of the 25 children who died from Covid in England during the 1st year of the pandemichttps://t.co/QK3gk1BXy5
Great that 99.995% of children w/ a positive test survived (not what is driving the need for 💉in kids) pic.twitter.com/moXKl8ysmA— Eric Topol (@EricTopol) November 11, 2021
A clinical review of all pediatric deaths in England from March 2020 to February 2021 attributes 25 deaths to SARS-CoV-2 infection and identifies risk factors to guide interventions, according to a @NatureMedicine article. https://t.co/Bpjhf5sgow pic.twitter.com/v24Zf9CsXK
— Nature Portfolio (@NaturePortfolio) November 11, 2021
Aumento da imunidade às vacinas contra COVID-19 – “Novos estudos destacam os benefícios imunológicos dos reforços da vacina contra COVID-19, mas ainda restam questões sobre como fazer o melhor uso de suprimentos globais limitados.”
12 Nov, 2021 | 13:46hBoosting immunity to COVID-19 vaccines – Nature Medicine
Mapa | O mundo segundo a cobertura vacinal contra Covid.
12 Nov, 2021 | 13:43hThe world according to covid vaccine coverage – The BMJ
Comentário no Twitter
A year since the first covid vaccines were announced, rollouts are under way all over the world—to differing degrees.
This map shows the percentage of national population to have received two doses of covid vaccinehttps://t.co/rIU3qeWXIK @munkeatlooi pic.twitter.com/zZHr1XXBe8
— The BMJ (@bmj_latest) November 11, 2021
Vigilância global, pesquisa e colaboração necessárias para aprimorar a compreensão e o tratamento da “long COVID”.
12 Nov, 2021 | 13:42hConteúdos relacionados:
Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)
OMS, CDC | Progresso global contra o sarampo fica ameaçado em meio à pandemia de COVID-19.
12 Nov, 2021 | 13:36hComunicado de imprensa: Global progress against measles threatened amidst COVID-19 pandemic – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
While reported #measles cases have fallen compared to previous years, progress toward measles elimination continues to decline and the risk of outbreaks is mounting, according to a 🆕 report from @CDCgov & WHO.
👉 https://t.co/EjRVRexcGd pic.twitter.com/KnBU5RZn5i
— World Health Organization (WHO) (@WHO) November 10, 2021
Diretrizes IDSA sobre prevenção de infecção para profissionais de saúde que cuidam de pacientes com COVID-19 suspeitada ou conhecida.
11 Nov, 2021 | 16:25h
Comentário no Twitter
New recommendation on the use of eye protection as well as revised recommendations and literature on the use of PPE now available in IDSA’s COVID-19 Infection Prevention Guideline: https://t.co/MiACvSoG92#COVID19Guidelines pic.twitter.com/Zp7s0Ely9J
— IDSA (@IDSAInfo) November 5, 2021